GlassScriptPhysician profile
Harish Venkataraj
NPI 1306490685
$946.19
in general payments reported to CMS, 2019-2025
11 companies · $371 in 2025
The $371 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $269 · 2020: $9.38 · 2022: $201 · 2024: $95.24 · 2025: $371.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $466.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $466.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cook Medical LLC | $285.74 | 2025 | Hemospray |
| Novartis Pharmaceuticals Corporation | $237.91 | 2019 | |
| Janssen Pharmaceuticals, INC | $124.19 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $95.24 | 2024 | Xifaxan |
| Medtronic, INC. | $77.04 | 2022 | |
| Janssen Biotech, INC. | $32.84 | 2025 | Tremfya |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $25.44 | 2019-2020 | |
| Cardiva Medical, INC. | $19.57 | 2025 | Optowire |
| Lilly USA, LLC | $16.52 | 2025 | Omvoh |
| Phathom Pharmaceuticals, INC. | $16.45 | 2025 | Voquezna |
| Genentech USA, INC. | $15.25 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Harish Venkataraj listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.